New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

Start Comparing ETFs Now!

›ETF Issuers›Samsung Asset Management›266420

266420

Samsung KODEX Healthcare ETF

Passive ETF Equity

Not rated

The 266420 Exchange Traded Fund (ETF) is provided by Samsung Asset Management. It is built to track an index: Korea KRX Health Care Index. The 266420 ETF provides physical exposure, so by buying it you actually own parts of all the 67 underlying holdings. This share class generates a stream of income by distributing dividends.

₩17,455

-₩55 (-0.31%) today

3:55 AM 08/07/26 Open

1D price range

₩17,285₩17,850

52W price range

₩15,052.13₩25,340.78

YTD Perf.

-21.06%

YTD Flows

Annualized volatility

Fund AuM

€42M

Share class AuM

€42M

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

KR7266420009

TER

0.45%

Inception date

3/27/2017

Issuer

Samsung Asset Management

Benchmark

Korea KRX Health Care Index

Replication method

Dividend policy

Distributing

Compare similar ETFs

ETF Name	1w perf.
143860 Mirae Asset TIGER HEALTH CARE ETF	+12.61%
253280 RISE Healthcare ETF	+12.68%
0056 Yuanta Taiwan Dividend Plus ETF	+5.49%
069500 Samsung KODEX 200 ETF	+17.05%
102110 Mirae Asset TIGER 200 ETF	+17.19%
NAFTRACISHRS iShares NAFTRAC ETF	-0.67%
278530 Samsung KODEX 200 Total Return ETF	+17.05%
XSEM iShares ESG Aware MSCI Emerging Markets Index ETF	+3.93%
091160 Samsung KODEX Semicon ETF	+20.94%
XEC iShares Core MSCI Emerging Markets IMI Index ETF	+7.56%
229200 Samsung KODEX KOSDAQ 150 ETF	+21.88%
VEE Vanguard FTSE Emerging Markets All Cap Index ETF	+5.09%
148020 RISE 200 ETF	+17.20%
ICOLCAP iShares Fondo Bursatil iShares COLCAP ETF	+1.68%
BOVA11 iShares Ibovespa Fundo de Indice	+0.76%

API

PerformanceDec 30, 2025 - Aug 5, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 06/30/26

Healthcare

93.31%

Industrials

4.69%

Consumer Non-Cyclicals

1.11%

Unavailable

0.16%

Other

0.73%

Latest 266420 news

No content available for this fund

FAQ about 266420

266420 is a Passive ETF. This ETF provides exposure to South Korean Health Care Equities.

266420 tracks the Korea KRX Health Care Index - KRW, through a full replication replication method.

266420 carries a total expense ratio (TER) of 0.45%, indicating the annual cost for holding the fund.

266420 was introduced to the market on March 27, 2017. It trades on South Korea

Samsung KODEX Healthcare ETF, 266420, is provided by Samsung Asset Management. Learn more about Samsung Asset Management here.

266420 oversees €42M in assets as of August 5, 2026.

266420 follows a distributing dividend policy, meaning it pays out income to investors.

As of June 30, 2026, 266420 has significant geographic allocations in Republic of Korea.

As of June 30, 2026, 266420 focuses largely on Healthcare, Industrials and Consumer Non-Cyclicals.

As of June 30, 2026, 266420 holds 67 positions in its portfolio, with 74.57% of assets concentrated in its top 15 holdings.

As of June 30, 2026, 266420 top three holdings include Celltrion, Inc., Alteogen, Inc. and SAMSUNG BIOLOGICS Co., Ltd..

The base currency of 266420 is KRW.

Top 10 holdings

Data as of 06/30/26

Celltrion, Inc.

20.31%

Alteogen, Inc.

11.30%

SAMSUNG BIOLOGICS Co., Ltd.

10.91%

HLB Co., Ltd.

4.69%

Yuhan Corp.

3.22%

ABL Bio, Inc.

3.17%

Peptron, Inc.

3.04%

LigaChem Biosciences, Inc.

2.98%

SK Biopharmaceuticals Co., Ltd.

2.61%

SAM CHUN DANG PHARM Co., Ltd.

2.40%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

The Ultimate ETF Comparison Tool - Try Now!

Samsung KODEX Healthcare ETF

FAQ about 266420

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US